Saturday 17 October 2026
Export BMGL’s income statement to Excel — free account
Basel Medical Group Ltd
BMGL Healthcare Medical Care Facilities
Basel Medical Group Ltd’s revenue for fiscal 2025 (year ended June 2025) was $8.9 million, up 20.0% from fiscal 2024.
3.95
0.04
+1.02%
Follow BMGL
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to June
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | — | — | — | — | 5.84 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | — | — | — | — | — | 112.80 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | — | — | 36 | 77 | ||||
| Revenue/emp, $m | — | — | — | — | — | — | — | — | 0.21 | 0.12 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | — | 7 | 9 | ||||
| Gross margin, % | — | — | — | — | — | — | — | — | 77.63 | 77.68 | |||||
| EBT | — | — | — | — | — | — | — | — | 2 | (10) | |||||
| EBT margin, % | — | — | — | — | — | — | — | — | 23.92 | (110.47) | |||||
| Net income | — | — | — | — | — | — | — | — | 2 | (10) | |||||
| Depreciation | — | — | — | — | — | — | — | — | 0 | 0 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | — | — | — | 5.48 | 5.69 | ||||
| Earnings | — | — | — | — | — | — | — | — | 1.13 | (6.12) | |||||
| Cash flow | — | — | — | — | — | — | — | — | 1.37 | (2.18) | |||||
| Capex | — | — | — | — | — | — | — | — | 0.00 | (0.03) | |||||
| Free cash flow | — | — | — | — | — | — | — | — | 1.36 | (2.21) | |||||
| Book value | — | — | — | — | — | — | — | — | 4.12 | 2.44 | |||||
| Shares, m | — | — | — | — | — | — | — | — | 1 | 2 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | — | — | — | ||||
| P/S | — | — | — | — | — | — | — | — | — | — | |||||
| P/B | — | — | — | — | — | — | — | — | 0.00 | 0.00 | |||||
| EV/Sales | — | — | — | — | — | — | — | — | 0.00 | 0.00 | |||||
| EV/FCF | — | — | — | — | — | — | — | — | 0.00 | 0.00 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | — | — | — | 2 | (3) | ||||
| Capex | — | — | — | — | — | — | — | — | 0 | 0 | |||||
| Free cash flow | — | — | — | — | — | — | — | — | 2 | (3) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | — | — | — | 7 | 2 | ||||
| Total debt | — | — | — | — | — | — | — | — | 3 | 3 | |||||
| Net debt | — | — | — | — | — | — | — | — | 2 | 0 | |||||
| Shareholders’ equity | — | — | — | — | — | — | — | — | 6 | 4 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | — | — | — | 0.00 | (75.17) | ||||
| ROIC | — | — | — | — | — | — | — | — | 16.29 | (13.62) | |||||
| ROE | — | — | — | — | — | — | — | — | 0.00 | (202.11) | |||||
Negative figures in brackets.
Fiscal years to Jun 2025
Charts ten years each
Basel Medical Group Ltd vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| DCGO DocGo Inc. | $27.9M | — (loss-making) | — (loss-making) | −8.70% (below 0%: shrinking) | n/m | −132.28% (below 0%: shrinking) | 30.52% | (24.41%) | Compare |
| PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR | $15.9M | — (loss-making) | 8.3× | +25,427.42% (above 0%: growing) | n/m | −206.36% (below 0%: shrinking) | 42.70% | (1.24%) | Compare |
| CCM Concord Medical Services Holdings Limited | $10.5M | — (loss-making) | — (loss-making) | +37.65% (above 0%: growing) | n/m | −281.45% (below 0%: shrinking) | (13.15%) | 0.00% | Compare |
| AMS American Shared Hospital Services | $8.4M | — (loss-making) | 1.8× | +19.22% (above 0%: growing) | n/m | +195.82% (above 0%: growing) | 17.00% | (7.22%) | Compare |
| CANOQ Cano Health, Inc. | $6.6M | — (loss-making) | — | −21.05% (below 0%: shrinking) | n/m | −43.68% (below 0%: shrinking) | 100.00% | (16.23%) | Compare |
| MODVQ ModivCare Inc. | $6.2M | — (loss-making) | — (loss-making) | −3.18% (below 0%: shrinking) | n/m | −3,767.70% (below 0%: shrinking) | 14.06% | (1.78%) | Compare |
| BMGL Basel Medical Group Ltd | $6.2M | — | — | — | — | — | — | — | |
| RHEP Adcare Health Systems Inc | $5.2M | 0.6× | — (loss-making) | +143.03% (above 0%: growing) | n/m | +224.45% (above 0%: growing) | 31.50% | (0.88%) | Compare |
| NIVF NewGenIvf Group Limited | $2.3M | — | — | — | — | — | — | — | Compare |
| Median of peers | $7.5M | — | — | +19.22% | — | −132.28% | 30.52% | (1.78%) |
Basel Medical Group Ltd (BMGL) key facts
- Concern: Basel Medical Group Ltd reported a net loss of $9.8 million, or a loss of $6.12 per share, for fiscal 2025.
- Strength: Basel Medical Group Ltd’s revenue for fiscal 2025 (year ended June 2025) was $8.9 million, up 20.0% from fiscal 2024.
- Basel Medical Group Ltd (BMGL) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
- As of October 16, 2026, BMGL traded at $3.95, a market capitalization of $6.2 million.
- Return on equity was −202.1% and debt-to-equity 1.39.